Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 1/2020

01-01-2020 | Hypertension | Capsule Commentary

Capsule Commentary on Shapiro et al., Impact of a Patient-Centered Behavioral Economics Intervention on Hypertension Control in a Highly Disadvantaged Population: a Randomized Trial

Author: Justin S. White, PhD

Published in: Journal of General Internal Medicine | Issue 1/2020

Login to get access

Excerpt

Shapiro and colleagues assessed the efficacy of an intervention that combines monetary incentives and promotion of intrinsic motivation to improve blood pressure (BP) control among low-income and racial/ethnic minority patients.1 Uncontrolled hypertension is a leading cause of premature death in these subgroups.2 The investigators found short-term improvements in BP control at 6 months when the incentives ended, although the effects had largely faded by 12 months. These findings are consistent with several other studies and highlight the challenges for inducing long-lasting behavior change, especially among high-risk, disadvantaged groups. …
Literature
1.
2.
3.
4.
5.
Sen AP, Huffman D, Loewenstein G, Asch DA, Kullgren JT, Volpp KG. Do financial incentives reduce intrinsic motivation for weight loss? Evidence from two tests of crowding out. In: Cohen IG, Fernandez Lynch H, Robertson CT, editors. Nudging Health: Health Law and Behavioral Economics. Baltimore, MD: JHU Press; 2016. p. 202-18.
Metadata
Title
Capsule Commentary on Shapiro et al., Impact of a Patient-Centered Behavioral Economics Intervention on Hypertension Control in a Highly Disadvantaged Population: a Randomized Trial
Author
Justin S. White, PhD
Publication date
01-01-2020
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 1/2020
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-05492-8

Other articles of this Issue 1/2020

Journal of General Internal Medicine 1/2020 Go to the issue

Original Research

Association of the Implementation of the Patient-Centered Medical Home with Quality of Life in Patients with Multimorbidity

Original Research

Awareness and Discussions About Chronic Kidney Disease Among African-Americans with Chronic Kidney Disease and Hypertension: a Mixed Methods Study

Capsule Commentary

Capsule Commentary on Stryczek et. al., De-implementing Inhaled Corticosteroids to Improve Care and Safety in COPD Treatment: Primary Care Providers’ Perspectives

Capsule Commentary

Capsule Commentary on Woodfine et. al., Criteria for Hyponatremic Overcorrection: Systematic Review and Cohort Study of Emergently Ill Patients

Original Research

Trends in Self-reported Prediabetes and Metformin Use in the USA: NHANES 2005–2014

Editorial

The Promise of Virtual Complex Care Management
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits